Biotech

Trillium Announces Voting Results from the Annual Meeting of Shareholders

TORONTO, ONTARIO: ...

Ceapro Inc. to Provide a Corporate Update to Shareholders on June 1, 2017

EDMONTON, ALBERTA: ...

Revive Therapeutics Ltd. Announces Results for the Three and Nine Months Ended March 31, 2017

TORONTO, ONTARIO: ...

CORRECTION - Cosmos Holdings, Inc. Announces first Quarter 2017 Results

CHICAGO, IL: ...

Announcements in Conjunction With Theratechnologies Annual Meeting

MONTREAL, QUEBEC: ...

Trillium Reports First Quarter 2017 Financial and Operating Results

TORONTO, ONTARIO: - Encouraging preliminary clinical observations suggesting activity of TTI-621 both as a single agent and in combination therapy - Expanded pharmacology data set demonstrating increased half-life and ...

Vinergy Resources Announces USD $200,000 Private Placement

VANCOUVER, BRITISH COLUMBIA: ...

Atossa Genetics Receives Second Positive Safety Committee Decision in Phase 1 Topical Endoxifen Dose Escalation Study

SEATTLE, WA: Final Topical Group Approved for Dosing ...

Atossa Genetics Receives Approval from Institutional Review Board for Continuation of its Fulvestrant Microcatheter Phase 2 Study

SEATTLE, WA: ...

Sernova Receives Approval to Extend Term of Warrants

LONDON, ONTARIO: ...